BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 5, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sectorBreaking News: House passes H.R. 1, restoring R&D tax cutsBreaking News: Self-amplifying mRNA technology underscored for next big pandemic
Home » Topics » BioWorld, Analysis and data insight

BioWorld, Analysis and data insight
BioWorld, Analysis and data insight RSS Feed RSS

Biopharmaceutical collaborations: December 2019

Jan. 24, 2020
Biopharma licensings, joint ventures and collaborations, including: Abbvie, Amyris, Athenex, Biocon, Bridgebio, Codexis, Eisai, Eli Lilly, Fulcrum, Genentech, Gilead, Hitgen, Janssen, Kodiak, Ligand, Merck, Mochida, Nicox, Onconova, Pulmatrix, Retrogenix, Sarepta, Sunesis, Tracon, Ultragenyx, Xbiotech
Read More
Illustration of big fish eating three smaller fish

Completed biopharmaceutical mergers & acquisitions: December 2019

Jan. 24, 2020
Completed biopharma M&As, including: Astellas, Cambrex, Castle Creek, Dendrimer, Effepharm, Fibrocell, Gemphire, Immunovant, J&J, Kyowa, Neurobo, Permira, Roche, Spark, Taris, Xyphos
Read More

Collaborations between biopharmaceutical companies and government/nonprofit entities: December 2019

Jan. 24, 2020
Deals between biopharma companies and government or nonprofit entities, including: Abbvie, Advaite, Aptahem, Baergic Bio, Bayer, Bellicum, Bloom Science, EMD Serono, Enochian, Evgen, Hoth, Indivior, Kazia, Regeneron, Sanofi Pasteur, Syntekabio, Theragnostics, Vaccitech
Read More

Biopharma money raised: Jan. 1-23, 2020

Jan. 24, 2020
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Money raised by biopharma: 2020 vs. 2019

Jan. 24, 2020
Total raised in public, private and other financings of biopharma companies, comparing 2020 vs. 2019.
Read More
DNA illustration

Significant year of growth for regenerative medicine sector

Jan. 22, 2020
By Peter Winter
According to Janet Lambert, CEO of the Alliance for Regenerative Medicine (ARM), in her delivery of the international advocacy group’s state of the industry briefing at Biotech Showcase in San Francisco, 2019 proved to be a significant year of growth for the regenerative medicine sector.
Read More
Observation telescope pointed at water

Quiet conference week, but biopharmas confident about the year ahead

Jan. 21, 2020
By Peter Winter
Investors have grown accustomed to hearing news of major announcements from big pharma and blue chip biotech companies during the J.P. Morgan Healthcare conference week. However, as it turned out, headline catalysts were in short supply. In the absence of any major M&A deals taking place, the event turned out to be unusually muted.
Read More

Week in review for Jan. 13-17, 2020: A quiet week at the J.P. Morgan Healthcare conference

Jan. 21, 2020
By Peter Winter
A quick look back at top stories.
Read More
Arrows pointing upward

Biggest gainers and losers for the week of Jan. 13-17, 2020

Jan. 17, 2020
The top 10 biopharma stock gainers and losers for the week.
Read More

Regulatory submissions, approvals and other actions: December 2019

Jan. 17, 2020
Regulatory decisions affecting biopharma products in development, including approvals, recommendations, rejections and the granting of regulatory pathways in December 2019.
Read More
Previous 1 2 … 182 183 184 185 186 187 188 189 190 … 202 203 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing